Abiopharma

News list

GILL JOHN 🟢 acquired 48.8K shares (1 derivative) of Altimmune, Inc. (ALT) at $2.82 Transaction Date: May 01, 2026 | Filing ID: 000004

Full text

News bot May 1, 2026, 8:09 p.m.
🔍 GILL JOHN (Executive)

Company: Altimmune, Inc. (ALT)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 48,800
Detailed Transactions and Holdings:
- Acquired 48,800 shares of Stock Options (option to buy) at $2.82 per share (Derivative)
  Date: 2026-05-01 | Code: A | Expires: 2036-05-01 | equity_swap_involved: 0 | shares_owned_after: 48,800.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The options were granted pursuant to the Company's non-employee director compensation policy.
- F2: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date.